investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Michele S Redell

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Hematology and hematologic malignancies

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies

Javier Adachi

Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions

Leukaemia

Hematology and hematologic malignancies

Ya-Huei Kuo

HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance

Leukaemia

Hematology and hematologic malignancies

Richard Aplenc

Toxicity Monitoring on Phase III Trials with Administrative Data

Leukaemia

Hematology and hematologic malignancies

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Hematology and hematologic malignancies

Frederick Appelbaum

Adult Leukemia Research Center

Leukaemia

Hematology and hematologic malignancies